These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22459357)

  • 21. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia.
    Mori F; Tanji K; Zhang HX; Nishihira Y; Tan CF; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2008 Aug; 116(2):193-203. PubMed ID: 18560845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases.
    Warraich ST; Yang S; Nicholson GA; Blair IP
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1606-9. PubMed ID: 20601083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions.
    Mackenzie IR; Foti D; Woulfe J; Hurwitz TA
    Brain; 2008 May; 131(Pt 5):1282-93. PubMed ID: 18362096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease.
    Rohn TT
    Brain Res; 2008 Sep; 1228():189-98. PubMed ID: 18634762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy.
    Thorpe JR; Tang H; Atherton J; Cairns NJ
    J Neural Transm (Vienna); 2008 Dec; 115(12):1661-71. PubMed ID: 18974920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoplasmic inclusions of TDP-43 in neurodegenerative diseases: a potential role for caspases.
    Rohn TT
    Histol Histopathol; 2009 Aug; 24(8):1081-6. PubMed ID: 19554515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
    Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
    J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells.
    Nonaka T; Arai T; Buratti E; Baralle FE; Akiyama H; Hasegawa M
    FEBS Lett; 2009 Jan; 583(2):394-400. PubMed ID: 19111550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.
    Wils H; Kleinberger G; Janssens J; Pereson S; Joris G; Cuijt I; Smits V; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3858-63. PubMed ID: 20133711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
    Prudlo J
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An
    Cascella R; Banchelli M; Abolghasem Ghadami S; Ami D; Gagliani MC; Bigi A; Staderini T; Tampellini D; Cortese K; Cecchi C; Natalello A; Adibi H; Matteini P; Chiti F
    Ann Med; 2023 Dec; 55(1):72-88. PubMed ID: 36495262
    [No Abstract]   [Full Text] [Related]  

  • 32. Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease.
    Brandmeir NJ; Geser F; Kwong LK; Zimmerman E; Qian J; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2008 Jan; 115(1):123-31. PubMed ID: 18004574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration.
    Dutta K; Patel P; Rahimian R; Phaneuf D; Julien JP
    Neurotherapeutics; 2017 Apr; 14(2):447-462. PubMed ID: 27928708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease.
    Tan CF; Yamada M; Toyoshima Y; Yokoseki A; Miki Y; Hoshi Y; Kaneko H; Ikeuchi T; Onodera O; Kakita A; Takahashi H
    Acta Neuropathol; 2009 Oct; 118(4):553-60. PubMed ID: 19526244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuropathology of frontotemporal lobar degeneration with ubiquitinated inclusions].
    Yoshida M
    Brain Nerve; 2009 Nov; 61(11):1308-18. PubMed ID: 19938688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.
    Kawakami I; Arai T; Hasegawa M
    Acta Neuropathol; 2019 Nov; 138(5):751-770. PubMed ID: 31555895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular dissection of TDP-43 proteinopathies.
    Hasegawa M; Nonaka T; Tsuji H; Tamaoka A; Yamashita M; Kametani F; Yoshida M; Arai T; Akiyama H
    J Mol Neurosci; 2011 Nov; 45(3):480-5. PubMed ID: 21678031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis.
    Sumi H; Kato S; Mochimaru Y; Fujimura H; Etoh M; Sakoda S
    J Neuropathol Exp Neurol; 2009 Jan; 68(1):37-47. PubMed ID: 19104447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [FTLD/ALS as TDP-43 proteinopathies].
    Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O
    Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T
    Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.